CN Patent

CN103565816A — 妥布霉素地塞米松滴眼液

Assigned to Tianjin Jinyao Group Co Ltd · Expires 2014-02-12 · 12y expired

What this patent protects

妥布霉素地塞米松滴眼液，含有作为活性成分的地塞米松微粉和妥布霉素，水和一种或几种适用于滴眼液的辅料，其特征在于，所述的地塞米松微粉，其粒径分布同时满足以下条件：D50为3.0-4.0μm，最大粒径小于30μm，粒径在1-5μm的微粉量，颗粒百分比为60%-66%，其中粒径在5-10μm的微粉，颗粒百分比为21%-26%,粒径小于等于10μm的微粉总量，颗粒百分比为92-98%。

USPTO Abstract

妥布霉素地塞米松滴眼液，含有作为活性成分的地塞米松微粉和妥布霉素，水和一种或几种适用于滴眼液的辅料，其特征在于，所述的地塞米松微粉，其粒径分布同时满足以下条件：D50为3.0-4.0μm，最大粒径小于30μm，粒径在1-5μm的微粉量，颗粒百分比为60%-66%，其中粒径在5-10μm的微粉，颗粒百分比为21%-26%,粒径小于等于10μm的微粉总量，颗粒百分比为92-98%。

Drugs covered by this patent

Patent Metadata

Patent number
CN103565816A
Jurisdiction
CN
Classification
—
Expires
2014-02-12
Drug substance claim
No
Drug product claim
No
Assignee
Tianjin Jinyao Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.